Neoadjuvant cabozantinib plus nivolumab before cytoreductive nephrectomy shows promising responses in metastatic clear cell RCC
Neoadjuvant cabozantinib plus nivolumab before cytoreductive nephrectomy shows promising responses in metastatic clear cell RCC
ASCO GU 2026: Updates in bladder cancer
ASCO GU 2026: Updates in metastatic prostate cancer
ASCO GU 2026: Updates in localised prostate cancer
Evaluation and definition of response and progression from trials to clinical practice
The Vanessa Moss Prize: celebrating research into cancer health disparities
Can public–private partnerships accelerate cancer research and clinical trials in LMICs?
Oral cancer prevention through community counselling in a tribal population
Global cancer burden, prevention, and inequalities across regions
Understanding breast cancer care systems with the BCCi
Strengthening cancer prevention through the Latin American cancer code
Reducing cancer burden through prevention